Advertisement
New Zealand markets open in 9 hours 47 minutes
  • NZX 50

    11,800.78
    -20.00 (-0.17%)
     
  • NZD/USD

    0.6012
    +0.0000 (+0.01%)
     
  • ALL ORDS

    8,065.50
    +113.20 (+1.42%)
     
  • OIL

    78.25
    -0.23 (-0.29%)
     
  • GOLD

    2,320.10
    -11.10 (-0.48%)
     

Viking Therapeutics Stock Rose 101% on May 31

Viking Therapeutics Stock Rose 101% on May 31

On May 31, Viking Therapeutics (VKTX), a California-based biotechnology firm, closed at $9.99—a rise of ~101% from the previous day’s closing price of $4.97. The stock price nearly doubled on the news of the positive Phase-II clinical trial results from Madrigal Pharmaceuticals’ (MDGL) NASH (non-alcoholic steatohepatitis) candidate MGL-3196. The news triggered a rise of ~150% in Madrigal Pharmaceuticals’ stock price. On the same day, the SPDR S&P Biotech ETF (XBI) rose ~1.5%.